Evidence map›Paper›PMID 37332560›Full record

ReviewInternational journal of ophthalmology2023

Epidemiological aspect of retinoblastoma in the world: a review of recent advance studies.

Leili Koochakzadeh, Abbasali Yekta, Hassan Hashemi, Reza Pakzad, Samira Heydarian, Mehdi Khabazkhoob

Open access · goldAbstract readReview
In one paragraph

Review in International journal of ophthalmology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 2 pooled it
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Global incidence and trends of ocular cancer: A bibliometric analysis.Advances in ophthalmology practice and research
    Article
  12. Article
  13. Retinoblastoma: Aqueous humor liquid biopsy.Taiwan journal of ophthalmology
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

Leili KoochakzadehDepartment of Pediatrics, Children's Medical Center Hospital, Tehran University of Medical Sciences, Tehran 1968653111, Iran.
Abbasali YektaRefractive Errors Research Center, Mashhad University of Medical Sciences, Mashhad 3453545, Iran.
Hassan HashemiNoor Research Center for Ophthalmic Epidemiology, Noor Eye Hospital, Tehran 1983963113, Iran.
Reza PakzadDepartment of Epidemiology, Faculty of Health, Ilam University of Medical Sciences, Ilam 6931851147, Iran.
Samira HeydarianDepartment of Rehabilitation Science, School of Allied Medical Sciences, Mazandaran University of Medical Sciences, Sari 4818893813, Iran.
Mehdi KhabazkhoobDepartment of Basic Sciences, School of Nursing and Midwifery, Shahid Beheshti University of Medical Sciences, Tehran 1968653111, Iran.
Children's Medical Center · IRMashhad University of Medical Sciences · IRMedical University of Ilam · IRNoor Eye Hospital · IRShahid Beheshti University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo collect and present updated evidence about epidemiological aspects of retinoblastoma (Rb) in the world.

methodsA comprehensive search without the time and language restrictions was conducted in international databases, including MEDLINE, Scopus, Web of Science, and PubMed. The search keywords were "retinoblastoma" OR "retinal Neuroblastoma" OR "retinal glioma" OR "retinoblastoma eye cancer" OR "retinal glioblastoma".

resultsThe worldwide incidence of Rb is 1 in 16 000-28 000 live births, but was higher in developing compared to developed countries. Several attempts for improving early detection and treatment had increased the Rb survival rate from 5% to 90% in developed countries over the past decade, but its survival was lower in developing countries (about 40% in low-income countries) and the majority of mortalities occurred in developing countries. The etiology of Rb could be viewed as genetics in the heritable form and environmental and lifestyle factors in the sporadic form. Some environmental risk factors such as

conclusionDetermining the role of genetics and environmental factors helps to accurately predict the prognosis and identify the mechanism of the disease, which can reduce the risk of tumor development.

Indexed as

childrenepidemiologyleukocoriaRB1 generetinoblastoma

Identifiers

PMID37332560
PMCPMC10250942
OpenAlexW4381158278

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.